Diego Llovet1,1, Mardie Serenity1, Lesley Gotlib Conn1,1, Caroline A Bravo1, Bronwen R McCurdy1, Catherine Dubé1,1, Nancy N Baxter1,1, Lawrence Paszat1,1, Linda Rabeneck1,1, Amanda Peters1, Jill Tinmouth1,1. 1. Cancer Care Ontario, Toronto, Canada. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. Sunnybrook Research Institute, Toronto, Canada. Department of Medicine, University of Ottawa, Ottawa, Canada. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Department of Surgery, St. Michael's Hospital, Toronto, Canada. Institute for Clinical Evaluative Sciences, Toronto, Canada. Department of Medicine, University of Toronto, Toronto, Canada. McMaster University, Hamilton, Canada.
Abstract
OBJECTIVES: Follow-up colonoscopy rates among persons with positive fecal occult blood test results (FOBT + ) remain suboptimal in many jurisdictions. In Ontario, Canada, primary care providers (PCPs) are responsible for arranging follow-up colonoscopies. The objectives were to understand the reasons for a lack of follow-up colonoscopy and any action plans to address follow-up. METHODS: Semi-structured interviews were conducted with 30 FOBT+ persons and 30 PCPs in Ontario. Eligible FOBT+ persons were identified through administrative databases and included those aged 50-74, with a 6-12 month old FOBT+, no follow-up colonoscopy, and no prior colorectal cancer diagnosis or colectomy. Eligible PCPs had ≥1 rostered FOBT+ person without follow-up colonoscopy. Transcripts were analyzed inductively using Nvivo 11 (QSR International Pty Ltd., 2015). RESULTS: Reasons for lack of follow-up colonoscopy were: person and/or provider believed the FOBT + was a false positive; person was afraid of colonoscopy; person had other health issues; and breakdown in communication of FOBT+ results or colonoscopy appointments. PCPs who initially recommended follow-up colonoscopy did not change the minds of the persons who dismissed the FOBT+ as a false positive and/or who were afraid of the procedure. These FOBT+ persons negotiated an alternative follow-up action plan including repeating the FOBT or not following-up. CONCLUSIONS: PCPs may not adequately counsel FOBT+ persons who believe the FOBT+ is a false positive and/or fear colonoscopy. PCPs may lack fail-safe systems to communicate FOBT+ results and colonoscopy appointments. Using navigators may help address these barriers and increase follow-up rates.
OBJECTIVES: Follow-up colonoscopy rates among persons with positive fecal occult blood test results (FOBT + ) remain suboptimal in many jurisdictions. In Ontario, Canada, primary care providers (PCPs) are responsible for arranging follow-up colonoscopies. The objectives were to understand the reasons for a lack of follow-up colonoscopy and any action plans to address follow-up. METHODS: Semi-structured interviews were conducted with 30 FOBT+ persons and 30 PCPs in Ontario. Eligible FOBT+ persons were identified through administrative databases and included those aged 50-74, with a 6-12 month old FOBT+, no follow-up colonoscopy, and no prior colorectal cancer diagnosis or colectomy. Eligible PCPs had ≥1 rostered FOBT+ person without follow-up colonoscopy. Transcripts were analyzed inductively using Nvivo 11 (QSR International Pty Ltd., 2015). RESULTS: Reasons for lack of follow-up colonoscopy were: person and/or provider believed the FOBT + was a false positive; person was afraid of colonoscopy; person had other health issues; and breakdown in communication of FOBT+ results or colonoscopy appointments. PCPs who initially recommended follow-up colonoscopy did not change the minds of the persons who dismissed the FOBT+ as a false positive and/or who were afraid of the procedure. These FOBT+ persons negotiated an alternative follow-up action plan including repeating the FOBT or not following-up. CONCLUSIONS: PCPs may not adequately counsel FOBT+ persons who believe the FOBT+ is a false positive and/or fear colonoscopy. PCPs may lack fail-safe systems to communicate FOBT+ results and colonoscopy appointments. Using navigators may help address these barriers and increase follow-up rates.
Authors: Ann Oluloro; Amanda F Petrik; Ann Turner; Tanya Kapka; Jennifer Rivelli; Patricia A Carney; Somnath Saha; Gloria D Coronado Journal: J Community Health Date: 2016-08
Authors: Theodore R Levin; Laura Jamieson; Daniel A Burley; Juan Reyes; Michael Oehrli; Cindy Caldwell Journal: Epidemiol Rev Date: 2011-06-27 Impact factor: 6.222
Authors: Adriano Correia; Linda Rabeneck; Nancy N Baxter; Lawrence F Paszat; Rinku Sutradhar; Lingsong Yun; Jill Tinmouth Journal: Prev Med Date: 2015-04-18 Impact factor: 4.018
Authors: Nadeem Baig; Ronald E Myers; Barbara J Turner; James Grana; Todd Rothermel; Neil Schlackman; David S Weinberg Journal: Am J Gastroenterol Date: 2003-09 Impact factor: 10.864
Authors: Sharon S Laing; Andy Bogart; Jessica Chubak; Sharon Fuller; Beverly B Green Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-11-12 Impact factor: 4.254
Authors: Vivy T Cusumano; Anthony Myint; Edgar Corona; Liu Yang; Jennifer Bocek; Antonio G Lopez; Marcela Zhou Huang; Naveen Raja; Anna Dermenchyan; Lily Roh; Maria Han; Daniel Croymans; Folasade P May Journal: Dig Dis Sci Date: 2021-02-20 Impact factor: 3.199
Authors: Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone Journal: CA Cancer J Clin Date: 2020-06-25 Impact factor: 286.130
Authors: Vivy T Cusumano; Edgar Corona; Diana Partida; Liu Yang; Christine Yu; Folasade P May Journal: BMC Gastroenterol Date: 2020-04-19 Impact factor: 3.067
Authors: Lucinda Bertels; Peter Lucassen; Kristel van Asselt; Evelien Dekker; Henk van Weert; Bart Knottnerus Journal: Scand J Prim Health Care Date: 2020-11-13 Impact factor: 2.581
Authors: Ashley C Mog; Peter S Liang; Lucas M Donovan; George G Sayre; Aasma Shaukat; Folasade P May; Thomas J Glorioso; Michelle A Jorgenson; Gordon Blake Wood; Candice Mueller; Jason A Dominitz Journal: Clin Transl Gastroenterol Date: 2022-02-01 Impact factor: 4.396
Authors: Giuseppa Minutolo; Palmira Immordino; Alessia Dolce; Mario Valenza; Emanuele Amodio; Walter Mazzucco; Alessandra Casuccio; Vincenzo Restivo Journal: Int J Environ Res Public Health Date: 2022-02-27 Impact factor: 3.390
Authors: Rachel B Issaka; Ari Bell-Brown; Cyndy Snyder; Dana L Atkins; Lisa Chew; Bryan J Weiner; Lisa Strate; John M Inadomi; Scott D Ramsey Journal: JAMA Netw Open Date: 2021-08-02